(Center for Genomic Regulation) A research effort led by Eulàlia Martí at the Centre for Genomic Regulation reveals new molecular mechanisms of Huntington's chorea. The results, recently published in the Journal of Clinical Investigation, question the approaches used up to now for treatment of the disease. They also point to messenger RNA as a key pathogenic component that will make it possible to define new therapeutic strategies.
The messenger in Huntington’s disease
Please login to join discussion
POPULAR NEWS
-
Breakthrough in Computer Hardware Advances Solves Complex Optimization Challenges
-
Physicists Develop Visible Time Crystal for the First Time
-
Tailored Gene-Editing Technology Emerges as a Promising Treatment for Fatal Pediatric Diseases
-
Scientists Achieve Ambient-Temperature Light-Induced Heterolytic Hydrogen Dissociation